Louis S. Harris

Affiliations: 
Virginia Commonwealth University School of Medicine, Richmond, VA 
Area:
Pharmacology, opioid, pain, analgesics
Website:
http://www.vcu.edu/pharmtox/about/history.htm
Google:
"Louis Harris"
Mean distance: 16.45 (cluster 32)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Ben Haddou T, Malfacini D, Calo G, et al. (2014) Exploring pharmacological activities and signaling of morphinans substituted in position 6 as potent agonists interacting with the μ opioid receptor. Molecular Pain. 10: 48
Aceto MD, Harris LS, Negus SS, et al. (2012) MDAN-21: A Bivalent Opioid Ligand Containing mu-Agonist and Delta-Antagonist Pharmacophores and Its Effects in Rhesus Monkeys. International Journal of Medicinal Chemistry. 2012: 327257
Moynihan HA, Derrick I, Broadbear JH, et al. (2012) Fumaroylamino-4,5-epoxymorphinans and related opioids with irreversible μ opioid receptor antagonist effects. Journal of Medicinal Chemistry. 55: 9868-74
Wise LE, Premaratne ID, Gamage TF, et al. (2012) l-theanine attenuates abstinence signs in morphine-dependent rhesus monkeys and elicits anxiolytic-like activity in mice. Pharmacology, Biochemistry, and Behavior. 103: 245-52
Tobey KM, Walentiny DM, Wiley JL, et al. (2012) Effects of the specific α4β2 nAChR antagonist, 2-fluoro-3-(4-nitrophenyl) deschloroepibatidine, on nicotine reward-related behaviors in rats and mice. Psychopharmacology. 223: 159-68
Vann RE, Tobey KM, Lobe SL, et al. (2011) Varenicline does not alter brain stimulation reward thresholds and reverses nicotine-facilitated thresholds in rats Drug Development Research. 72: 310-314
Kwilasz AJ, Harris LS, Vann RE. (2009) Removal of continuous nicotine infusion produces somatic but not behavioral signs of withdrawal in mice. Pharmacology, Biochemistry, and Behavior. 94: 114-8
Cami-Kobeci G, Neal AP, Bradbury FA, et al. (2009) Mixed kappa/mu opioid receptor agonists: the 6 beta-naltrexamines. Journal of Medicinal Chemistry. 52: 1546-52
Metcalf MD, Aceto MD, Harris LS, et al. (2008) The influence of esters and carboxylic acids as the N-substituent of opioids. Part 1: Benzomorphans. Bioorganic & Medicinal Chemistry. 16: 869-73
Hiebel AC, Lee YS, Bilsky E, et al. (2007) Probes for narcotic receptor mediated phenomena. 34. Synthesis and structure-activity relationships of a potent mu-agonist delta-antagonist and an exceedingly potent antinociceptive in the enantiomeric C9-substituted 5-(3-hydroxyphenyl)-N-phenylethylmorphan series. Journal of Medicinal Chemistry. 50: 3765-76
See more...